Omvoh (mirikizumab-mrkz) is a prescription drug that’s used to treat ulcerative colitis in adults. Omvoh comes as a liquid solution that’s given as an injection under your skin or as an intravenous ...

Significantly more patients with moderately to severely active ulcerative colitis achieved clinical remission with the investigational monoclonal antibody tulisokibart compared with placebo, a ...

Dec. 3 (UPI) --Privately owned, standalone infusion centers are increasingly providing a comfortable and convenient alternative to hospitals and doctors' offices for people on prescribed medications ...

ORLANDO -- Vedolizumab (Entyvio) and infliximab (Remicade) led to mostly similar 1-year outcomes in patients with ulcerative colitis previously untreated with a biologic, but the integrin receptor ...

The lowest effective recommended dosage should be used to maintain therapeutic response. The Food and Drug Administration (FDA) has approved Tremfya ® (guselkumab) for the treatment of adult patients ...

Avsola (infliximab-axxq) is a prescription drug used to treat certain autoimmune conditions. It’s given as an intravenous (IV) infusion by a doctor or other healthcare professional. Your dosage will ...

Please provide your email address to receive an email when new articles are posted on . The FDA has approved Eli Lilly’s Omvoh infusion/injection as the “first and only” interleukin-23p19 antagonist ...

Omvoh (mirikizumab-mrkz) is a brand-name drug that’s prescribed for moderate to severe active ulcerative colitis (UC) in adults. It is available as an intravenous (IV) or subcutaneous injection. The ...

A new drug for treating a type of inflammatory bowel disease (IBD) has been given the go-ahead by the Food and Drug Administration. On Friday, the FDA approved Pfizer’s etrasimod, branded as Velsipity ...